New prohibited substance case under FEI Anti-Doping Rules
The FEI has announced an adverse analytical finding involving a prohibited substance under the FEI Anti-Doping Rules.
Samples taken at the CSI 4* at Coapexpan (MEX) on 14 October 2016 from the horse La Petite Fleur 6 (FEI ID 103TN40/MEX), ridden by Andres Arozarena (FEI ID 10094207/MEX) to finish as runner-up in the speed class on the second day of the event, have returned positive for Piroxicam.
Piroxicam, a non-steroidal anti-inflammatory drug used for the treatment of rheumatic disorders, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
The athlete has been provisionally suspended from the date of notification (20 December 2016). The horse has also been suspended for a two-month period.
Further details on this case can be found here.
Suzanne Ashton, Founder of Everything Horse (Est, 2012), has a BA Hons in Marketing Management and a Diploma in Equine Science. Suzanne has ridden and owned horses all her life and has twelve years of experience in marketing, writing, design, SEO, and website creation.
Discover more from Everything Horse Magazine
Subscribe to get the latest posts sent to your email.